Search research articles
Contact Us
Filters
Showing results (41-50 of 109) with videos related to
Page
of 11
Sort By:
Radiation Research
|
August 1, 1997
Intracranial tumors after radium treatment for skin hemangioma during infancy--a cohort and case-control study
P Karlsson, E Holmberg, L M Lundberg, et al.
European Journal of Haematology
|
May 5, 1999
Survival in conventionally treated younger (<60 years) multiple myeloma patients: no improvement during two decades. Nordic Myeloma Study Group (NMSG)
M Hjorth, E Holmberg, S Rödjer, et al.
European Journal of Haematology
|
February 1, 1993
Initial versus deferred melphalan-prednisone therapy for asymptomatic multiple myeloma stage I--a randomized study. Myeloma Group of Western Sweden
M Hjorth, L Hellquist, E Holmberg, et al.
The Journal of Urology
|
June 30, 2022
Prostate Specific Antigen and Biopsy Contamination in the Göteborg-1 Randomized, Population-Based, Prostate Cancer Screening Trial
K Stinesen Kollberg, E Holmberg, A Josefsson, et al.
British Journal of Cancer
|
February 13, 2001
Genetic epidemiology of glioma
B Malmer, L Iselius, E Holmberg, et al.
Acta Dermato-Venereologica
|
January 1, 1997
Fine mapping of the locus for nevoid basal cell carcinoma syndrome on chromosome 9q
A B Undén, M Ståhle-Bäckdahl, E Holmberg, et al.
Magnetic Resonance Imaging
|
January 1, 1991
Gadolinium-labeled liposomes containing amphiphilic Gd-DTPA derivatives of varying chain length: targeted MRI contrast enhancement agents for the liver
G W Kabalka, M A Davis, E Holmberg, et al.
Clinical Genetics
|
June 4, 1998
DGGE screening of mutations in mismatch repair genes (hMSH2 and hMLH1) in 34 Swedish families with colorectal cancer
T Liu, S Wahlberg, C Rubio, et al.
American Journal of Medical Genetics
|
December 1, 1991
Association of the Robin sequence with the fragile X syndrome
A M Lachiewicz, S F Hoegerman, G Holmgren, et al.
British Journal of Haematology
|
February 1, 1990
Initial treatment in multiple myeloma: no advantage of multidrug chemotherapy over melphalan-prednisone. The Myeloma Group of Western Sweden
M Hjorth, L Hellquist, E Holmberg, et al.
Page
of 11
Search research articles
Search
Showing results (41-50 of 109) with videos related to
Sort By:
Page
of 11
Radiation Research
|
August 1, 1997
Intracranial tumors after radium treatment for skin hemangioma during infancy--a cohort and case-control study
P Karlsson, E Holmberg, L M Lundberg, et al.
European Journal of Haematology
|
May 5, 1999
Survival in conventionally treated younger (<60 years) multiple myeloma patients: no improvement during two decades. Nordic Myeloma Study Group (NMSG)
M Hjorth, E Holmberg, S Rödjer, et al.
European Journal of Haematology
|
February 1, 1993
Initial versus deferred melphalan-prednisone therapy for asymptomatic multiple myeloma stage I--a randomized study. Myeloma Group of Western Sweden
M Hjorth, L Hellquist, E Holmberg, et al.
The Journal of Urology
|
June 30, 2022
Prostate Specific Antigen and Biopsy Contamination in the Göteborg-1 Randomized, Population-Based, Prostate Cancer Screening Trial
K Stinesen Kollberg, E Holmberg, A Josefsson, et al.
British Journal of Cancer
|
February 13, 2001
Genetic epidemiology of glioma
B Malmer, L Iselius, E Holmberg, et al.
Acta Dermato-Venereologica
|
January 1, 1997
Fine mapping of the locus for nevoid basal cell carcinoma syndrome on chromosome 9q
A B Undén, M Ståhle-Bäckdahl, E Holmberg, et al.
Magnetic Resonance Imaging
|
January 1, 1991
Gadolinium-labeled liposomes containing amphiphilic Gd-DTPA derivatives of varying chain length: targeted MRI contrast enhancement agents for the liver
G W Kabalka, M A Davis, E Holmberg, et al.
Clinical Genetics
|
June 4, 1998
DGGE screening of mutations in mismatch repair genes (hMSH2 and hMLH1) in 34 Swedish families with colorectal cancer
T Liu, S Wahlberg, C Rubio, et al.
American Journal of Medical Genetics
|
December 1, 1991
Association of the Robin sequence with the fragile X syndrome
A M Lachiewicz, S F Hoegerman, G Holmgren, et al.
British Journal of Haematology
|
February 1, 1990
Initial treatment in multiple myeloma: no advantage of multidrug chemotherapy over melphalan-prednisone. The Myeloma Group of Western Sweden
M Hjorth, L Hellquist, E Holmberg, et al.
Page
of 11